Xueyao Han
-
- Diabetes Treatment and Management 35
- Diabetes Management and Research 26
- Diet, Metabolism, and Disease 10
- Diabetes, Cardiovascular Risks, and Lipoproteins 10
- Physiology top 5%
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer 18
- Genetics top 10%
- Diabetes and associated disorders 17
- Endocrine and Autonomic Systems top 10%
-
- Pancreatic function and diabetes 30
-
- Liver Disease Diagnosis and Treatment 13
- Co-authors
- Linong JiXiaoling CaiXianghai ZhouWenjia YangYingying LuoXiuying ZhangXueying GaoYifei Chen
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (6 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xueyao Han
122 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 121
- Endocrinology, Diabetes and Metabolism 882
- Physiology 398
- Molecular Biology 810
- Genetics 313
- Endocrine and Autonomic Systems 64
Countries citing papers authored by Xueyao Han
This map shows the geographic impact of Xueyao Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyao Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyao Han more than expected).
Fields of papers citing papers by Xueyao Han
This network shows the impact of papers produced by Xueyao Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyao Han. The network helps show where Xueyao Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xueyao Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 6 | |
| 8 | Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China | 2020 | 2 |
| 9 | 2020 | 2 | |
| 10 | 2018 | 27 | |
| 11 | 2017 | 43 | |
| 12 | 2017 | 145 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 20 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 36 | |
| 17 | 2013 | 25 | |
| 18 | Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. | 2009 | 40 |
| 19 | [Contribution of MODY6 gene in the pathogenesis of familial type 2 diabetes in Chinese population]. | 2005 | 7 |
| 20 | Induction of long-term good glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment | 2003 | 1 |
About Xueyao Han
Xueyao Han is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 126 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (35 papers), Pancreatic function and diabetes (30 papers), Diabetes Management and Research (26 papers), Metabolism, Diabetes, and Cancer (18 papers), Diabetes and associated disorders (17 papers), Liver Disease Diagnosis and Treatment (13 papers), Diet, Metabolism, and Disease (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (882 citations), Physiology (398 citations) and Molecular Biology (810 citations). Xueyao Han has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Linong Ji, Xiaoling Cai, Xianghai Zhou, Wenjia Yang, Yingying Luo, Xiuying Zhang, Xueying Gao, Linong Ji, Yifei Chen and Simin Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.